Related Experiment Video
Updated: May 27, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[How to effectively use methotrexate in rheumatoid arthritis?]
1Servicio de Reumatología, Hospital de Cruces, Baracaldo, Vizcaya, España. samuel.hernandezbaldizon@osakidetza.net
Reumatologia Clinica
|November 18, 2011
Summary
Methotrexate is a key drug for rheumatoid arthritis, but its optimal use is debated. This article offers a simplified, individualized dosing strategy based on current evidence and guidelines.
Area of Science:
- Rheumatology
- Pharmacology
- Clinical Medicine
Context:
- Methotrexate (MTX) is a primary treatment for rheumatoid arthritis (RA).
- Current clinical practice shows variability in MTX administration routes, initial doses, and titration schedules.
- Lack of consensus hinders optimal patient outcomes.
Purpose:
- To propose a simplified, evidence-based outline for MTX use in RA.
- To provide an individualized approach to MTX therapy, considering pharmacological aspects.
- To review adverse effects and monitoring strategies for MTX treatment.
Summary:
- This article presents a practical framework for initiating and escalating Methotrexate therapy in rheumatoid arthritis patients.
- The proposed strategy integrates pharmacological principles with recent high-impact journal recommendations.
- It addresses common uncertainties regarding dosing and administration routes.
Impact:
- Aims to standardize and optimize Methotrexate treatment protocols for RA.
- Facilitates evidence-based decision-making for clinicians managing rheumatoid arthritis.
- Enhances patient care by providing clear guidelines on MTX therapy and side effect management.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...